Overconsumption of Contrast Media in Percutaneous Coronary Intervention: Focusing on Cost and Acute Kidney Injury
Irrational use of medicines is a major problem worldwide. Since iodixanol (Visipaque®) was categorized in Category I based on the ABC-VED analysis in our hospital, we evaluated the amount of visipaque use and estimated the incremental cost based on the Maximum Contrast Dose (MCD) following irrationa...
Saved in:
Main Authors: | Marziye Jafari (Author), Gohar Eslami (Author), Babak Bagheri (Author), Shirin Asghari Vaskasi (Author), Shafagh Eslami (Author) |
---|---|
Format: | Book |
Published: |
Mazandaran University of Medical Sciences,
2019-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Protective Effect of Nicorandil on Contrast-Induced Acute Kidney Injury After Emergency Percutaneous Coronary Intervention
by: Zuo-zhong Yu PhD, et al.
Published: (2023) -
Contrast-associated acute kidney injury after percutaneous coronary interventions in patients with acute coronary syndrome: a real-world study
by: Vladimir A. Kuznetsov, et al.
Published: (2022) -
Predictive value of SII and sd-LDL for contrast-induced acute kidney injury in STEMI patients undergoing percutaneous coronary intervention
by: Guoqi Shen, et al.
Published: (2022) -
Assessment of the economic evaluation of the contrast agent Iomeron in percutaneous coronary intervention
by: A. S. Kolbin, et al.
Published: (2018) -
Remote Ischemic Preconditioning and Contrast-Induced Acute Kidney Injury in Patients Undergoing Elective Percutaneous Coronary Intervention: A Randomized Clinical Trial
by: Karolina Stokfisz, MD, et al.
Published: (2020)